> one of their defendable moats is the patent not on the compound itself, but on the injectors. Which is far longer. That is very typical in the drug/medical i

> one of their defendable moats is the patent not on the compound itself, but on the injectors. Which is far longer. That is very typical in the drug/medical industry. To the point where it is sometimes (often? usually?) an intentional strategy. https://sites.uclawsf.edu/evergreensearch/ https://sites.uclawsf.edu/evergreensearch/